Fake data from trial sites ruin studies, drug firms say.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41505532.
- Also identified by DOI 10.1126/science.aef2599.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alzheimer's drug developer accuses companies it hired of providing "medically impossible" results.
Medical subject headings
- Alzheimer Disease
- Drug Development
- Drug Industry
- Scientific Misconduct